1. Home
  2. ELMD vs TTRX Comparison

ELMD vs TTRX Comparison

Compare ELMD & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electromed Inc.

ELMD

Electromed Inc.

HOLD

Current Price

$39.45

Market Cap

326.9M

Sector

Health Care

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$9.46

Market Cap

285.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELMD
TTRX
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
326.9M
285.1M
IPO Year
2010
2025

Fundamental Metrics

Financial Performance
Metric
ELMD
TTRX
Price
$39.45
$9.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$36.00
$8.00
AVG Volume (30 Days)
48.1K
51.8K
Earning Date
05-12-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
46.55
N/A
EPS
0.91
N/A
Revenue
$54,716,000.00
N/A
Revenue This Year
$15.59
N/A
Revenue Next Year
$11.51
N/A
P/E Ratio
$43.96
N/A
Revenue Growth
13.83
N/A
52 Week Low
$19.93
$2.57
52 Week High
$47.40
$11.69

Technical Indicators

Market Signals
Indicator
ELMD
TTRX
Relative Strength Index (RSI) 44.85 51.22
Support Level $35.61 $2.95
Resistance Level $43.61 $10.72
Average True Range (ATR) 1.41 0.82
MACD -0.22 -0.10
Stochastic Oscillator 19.53 32.45

Price Performance

Historical Comparison
ELMD
TTRX

About ELMD Electromed Inc.

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: